DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
© ANZDATA Registry CANCER CHAPTER CHAPTER 10. © ANZDATA Registry CharacteristicMyelomaNon-Myeloma n%n% Total (%)807153,37199 Country of residence Australia ,25683.
UK Renal Registry 16th Annual Report Figure 5.1. Flow chart showing number of patients included in the various analyses.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
Nancy Briggs Kylie Hurst Stephen McDonald CHAPTER 4 METHOD AND LOCATION OF DIALYSIS 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
© ANZDATA Registry TRANSPLANTATION CHAPTER 5. © ANZDATA Registry Figure 8.1 Number of Kidney Transplant Operations Total (Living Donors) Year Australia.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN Annual Report—35th Edition ANZDATA Registry Annual Report.
Chapter 1 Incidence of End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
© ANZDATA Registry PEADIATRIC CHAPTER CHAPTER 11.
TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
Chapter 11 Paediatrics 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Paediatric.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Kidney Donors ANZDATA Annual Report 2014 Chapter 9.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
UK Renal Registry 13th Annual Report
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
First-year death rates by modality figure 8
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 18th Annual Report
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
CHAPTER 5 Paediatric Renal Replacement Therapy
ANZDATA 2014 Annual Report Chapter 11
In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’  Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.
ANZDATA Registry Annual Report 2013
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
UK Renal Registry 14th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
Update from the Haemodialysis Working Group
Dialysis outcomes in Australia & New Zealand
Stock and Flow of Haemodialysis Patients Australia
Figure 3.1 Death Rates by States All Dialysis Patients
Figure Prevalence of coronary artery disease by year or
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

DEATHS CHAPTER 3

© ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period (Years) Proportion Surviving Aust (95 % CI) Proportion Surviving NZ (95 % CI) 0– ( )95 ( ) 2 93 ( )93 ( ) 5 90 ( )75 ( ) 25— ( )99 ( ) 2 91 ( )94 ( ) 5 80 ( )74 ( ) 45— ( )90 ( ) 2 84 ( )80 ( ) 5 60 ( )52 ( ) 65— ( )84 ( ) 2 72 ( )71 ( ) 5 40 ( )34 ( ) 75— ( )76 ( ) 2 63 ( )54 ( ) 5 25 ( )20 ( ) ( )64 ( ) 2 49 ( )42 ( ) 5 16 ( )19 (7 - 36)

© ANZDATA Registry Figure 3.2 Death Rates During Renal Replacement Therapy All Patients Included who Received Treatment During 2010 Group Dialysis Mortality Rate (per 100 patient years, 95% CI) Dialysis Number of Deaths Included in Analysis Transplant Mortality Rate (per 100 patient years, 95% CI) Transplant Number of Deaths Included in Analysis O VERALL Australia ( ) ( )173 New Zealand ( ) ( )39 A GES (Y EARS ) < ( )20.30 ( )6 25— ( ) ( )26 45— ( ) ( )125 65— ( ) ( )55 ≥ ( ) D IABETES ( AT RRT START ) Non-diabetic ( ) ( )141 Type ( ) ( )23 Type ( ) ( )48 C ORONARY A RTERTY D ISEASE ( AT RRT START ) No 9.71 ( ) ( )163 Yes ( ) ( )49 I NDIGENOUS Non-Indigenous (Australia) ( ) ( )156 Non-Indigenous (New Zealand) ( ) ( )32 Aboriginal /Torres Strait Islanders ( ) ( )17 Maori (in New Zealand) ( ) ( )7 Pacific People (in New Zealand) 9.17 ( )41 --

© ANZDATA Registry Figure 3.3

© ANZDATA Registry Figure 3.4 Survival of Dialysis Patients by age Age Groups at start of treatment Median (25th and 75th centiles), years Australia 0-24 years years( ) years6.06 ( ) years3.99 ( ) years2.87 ( ) years 1.94 ( ) New Zealand 0-24 years( ) years7.83 ( ) years4.78 ( ) years3.41 ( ) years2.37 ( ) years 1.69 ( )

© ANZDATA Registry Figure 3.5 Survival by Age & Comorbidity amongst older age groups Median (25th and 75th centiles) Age Groups Any Vascular Disease DiabetesAustralia New Zealand yearsNo 5.75 (3.2 - ) 4.77 ( ) NoYes5.57 ( ) 4.75 ( ) YesNo4.18 ( ) 3.32 ( ) Yes 3.49 ( ) 3.03 ( ) yearsNo 4.65 ( ) 4.58 ( ) NoYes4.87 ( ) 3.09 ( ) YesNo3.56 ( ) 2.65 ( ) Yes 2.80 ( ) 2.77 ( ) yearsNo 3.99 ( ) 3.27 ( ) NoYes3.27 ( ) 3.82 ( ) YesNo2.85 ( ) 2.05 ( ) Yes 2.68 ( ) 1.85 ( ) yearsNo 3.19 ( ) 2.67 ( ) NoYes2.69 ( ) 3.27 ( ) YesNo2.36 ( ) 1.71 ( ) Yes 2.12 ( ) 3.32 ( ) yearsNo 3.07 ( ) 1.30 ( ) NoYes4.02 ( ) YesNo1.82 ( ) 1.70 ( ) Yes 1.49 ( ) 1.20 ( )

© ANZDATA Registry Figure 3.6

© ANZDATA Registry Figure 3.7

© ANZDATA Registry Figure 3.8 Modality at time of death and Age at death –2010 Cause of Death Haemodialysis Peritoneal Dialysis Transplant ≥ ≥ ≥75 Australia Cardiovascular Withdrawal Cancer Infection Other New Zealand Cardiovascular Withdrawal Cancer Infection Other

© ANZDATA Registry Figure 3.9 Death due to withdrawal-2010 WithdrawalHaemodialysis Peritoneal Dialysis TransplantTotal Australia Psychosocial Patient refused further2002 Suicide0011 Cardiovascular comorbidity Cerebrovascular comorbidity Peripheral vascular comorbidity Malignancy related withdrawal Withdrawal due to dia Total New Zealand Psychosocial Suicide1001 Cardiovascular comorbidity Cerebrovascular comorbidity3216 Peripheral vascular comorbidity74011 Malignancy related withdrawal6219 Total

© ANZDATA Registry Figure 3.10